Hepatitis E
What's New
Last Posted: May 14, 2024
- High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response
- Predicting Incidence of Hepatitis E Using Machine Learning in Jiangsu Province, China.
Cheng Xiaoqing et al. Epidemiology and infection 2022 1-11 - Mystery hepatitis cases in kids linked to unexpected viral suspect
J Kaiser, Science, May 25, 2022 - COVID-19 vaccines for children
JS Gerber et al, Science, November 19, 2021 - Evidence Used to Update the List of Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19
CDC Science Brief, October 14, 2021 - Hepatitis B: a new weapon against an old enemy
TJ Liang, Nature Medicine, October 12, 2021 - Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
E Lawitz et al, ancet Gastro Hepato, June 9, 2020 - CDC Recommendations for Hepatitis C Screening Among Adults in the United States
CDC, April 2020 - Predicting Hepatitis B Virus Infection Based on Health Examination Data of Community Population.
Wang Ying et al. International journal of environmental research and public health 2019 Dec 16(23) - Management of Hepatitis C in 2019.
Marks Kristen et al. JAMA 2019 May
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: